REFERENCES
- Ross R, Glomset J. The pathogenesis of athero-sclerosis. N Eng J Med 1976; 295: 369–77.
- Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med 1986; 20: 488–500.
- Shimokado K. Atherosclerosis and PDGF. Hor-mone and Clinic 1994; 42: 941–7.
- Shibutani T, Kanda A, Ishigai Y, Mori T, Chiba K, Tanaka M, Tachizawa H. Inhibitory effect of perindpril, a novel angiotensin-converting enzyme inhibitor, on neointima formation after balloon injury in rats and cholesterol-fed rabbits. J Cardiovasc Pharmacol 1994; 24: 509–16.
- Jonasson L, Holm J, Skalli 0, Bondiers G, Hansson GK. Regional accumulations of T-cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986; 6: 131–8.
- Nikol S, Huehns TY, Hofling B. Molecular biology and post-angioplasty restenosis. Athero-sclerosis 1996; 123: 17–31.
- Gruntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary artery steno-sis: percutaneous transluminal coronary angio-plasty. N Engl J Med 1979; 301: 61–8.
- Myler RM, Shaw RE, Stertzer SH, Clark DA, Fishman J, Murphy MG. Recurrence after cor-onary angioplasty. Cathet Cardiovasc Diagn 1987; 13: 77–86.
- Curb JD, Borhani NO, Enwislew G. Isolated systolic hypertension in 14 communities. Am J Epidemiol 1985; 121: 362–70.
- Nobuyoshi M, Kimura F K, Ohishi H, Horiuchi H, Nosaka H, Hamasaki N, Yokoi H, Kim K. Restenosis after percutaneous transluminal cor-onary angioplasty: pathologic observations in 20 patients. JACC 1991; 17: 433–9.
- Waller BF, Pinkerton CA, Orr CM, Slack JDS, Vantassel JW, Peters T. Restenosis 1 to 24 months after clinically successful coronary balloon angio-plasty: a necropsy study of 20 patients. JACC 1991; 17: 58B–70B.
- Lindner V, Fingerle J, Reidy MA. Mouse model of arterial injury. Circ Res 1993; 73: 792–6.
- Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothe-lium. Lab Invest 1983; 49: 327–33.
- Hirosumi J, Nomoto A, Ohkubo Y. Inflammatory responses in cuff-induced atherosclerosis in rab-bits. Atherosclerosis 1987; 64: 243–54.
- Kusakabe M, Sakakura T, Nishizaki Y, Sano M, Matsukage A. Polyester wax embedding and sectioning technique for immunohistochemistry. Stain Technol 1984; 59: 127.
- Claesson-Welsh L, Eriksson A, Westermark B, Heldin CH. cDNA cloning and expression of the human A-type platelet-derived growth factor (PDGF) receptor establishes structural similarity to the B-type PDGF receptor. Proc Natl Acad Sci USA 1989; 86: 4917–21.
- Yamada N, Kato M, Yamashita H, Nister M, Miyazono K, Heldin C-H, Funa K. Enhanced expression of transforming growth factor-13 and its type-I and type-II receptors in human glioblas-toma. Int J Cancer 1995; 62: 386–92.
- Robinson kA, Roubin GS, Siegel RJ, Black AJ, APkarian RP, King SB. Intraarterial stenting in the atherosclerotic rabbit. Circulation 1988; 78: 646— 53.
- Hanke H, Strohschneider T, Oberhoff M, Betz E, Karsch KR. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ Res 1990; 67: 651–9.
- Sarembock U, Laveau PJ, Sigal SL. Influence of inflation pressure and ballon size on the develop-ment of intimal hyperplasia after balloon angio-plasty: a study in the atherosclerotic rabbit. Circulation 1989; 80: 1029–40.
- Koyama H, Reidy MA. Reinjury of arterial lesions induces intimal smooth muscle cell replica-tion that is not controlled by fibroblast growth factor 2. Circ Res 1997; 80: 408–17.
- Kawarura M, Terashita Z, Okuda H, Imura Y, Shino A, Nakano M, Nishikawa K. TCV-116, a novel angiotensin II receptor antagonist, prevents intimal thickening and impairment of vascular function after carotid injury in rats. J Pharmacol Exp Ther 1993; 266: 1664–9.
- Hedin U, Bottger BA, Forsberg E, Johansson S, Thyberg J. Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells. J Cell Biol 1988; 107: 307–19.
- Bauriedel G, Kandolf R, Welsch U, Hofling B. Mechanisms of re-stenosis after angioplasty. Zeitschrift fur Kardiologie 1994; Suppl 83: 31–41.
- Tanabe S, Ueda M, Han YS, Nakatani T, Kishimoto T, Suzuki S, Amemiya H. Enhanced fibronectin expression is associated with the development of graft arteriosclerosis in human renal allografts. Transplant Proc 1995; 27: 1078–81.